SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Commission File Number 1-5620
SAFEGUARD SCIENTIFICS, INC.
| Pennsylvania | 23-1609753 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification Number) |
| 800 The Safeguard Building, | ||
| 435 Devon Park Drive Wayne, PA | 19087 | |
| (Address of principal executive offices) | (Zip Code) |
(610) 293-0600
Registrants telephone number, including area code
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).
Number of shares outstanding as
of April 25, 2003
Common Stock 119,310,523
SAFEGUARD SCIENTIFICS, INC.
QUARTERLY REPORT FORM 10-Q
INDEX
| Page | |||||
PART I - FINANCIAL INFORMATION |
|||||
Item 1 - Financial Statements: |
|||||
Consolidated Balance Sheets - March 31, 2003 (unaudited) and December 31, 2002 |
3 | ||||
Consolidated Statements of Operations (unaudited) - Three Months Ended March 31,
2003 and 2002 |
4 | ||||
Consolidated Statements of Cash Flows (unaudited) - Three Months Ended March 31,
2003 and 2002 |
5 | ||||
Notes to Consolidated Financial Statements |
6 | ||||
Item 2 - Managements Discussion and Analysis of Financial Condition and Results of Operations |
26 | ||||
Item 3 - Quantitative and Qualitative Disclosures About Market Risk |
35 | ||||
Item 4 Controls and Procedures |
35 | ||||
PART II - OTHER INFORMATION |
|||||
Item 1 - Legal Proceedings |
36 | ||||
Item 6 - Exhibits and Reports on Form 8-K |
36 | ||||
Signatures |
37 | ||||
Certifications |
38 | ||||
2
SAFEGUARD SCIENTIFICS, INC.
CONSOLIDATED BALANCE SHEETS
| March 31, | December 31, | |||||||||||
| 2003 | 2002 | |||||||||||
| (in thousands except per share data) | ||||||||||||
| (unaudited) | ||||||||||||
Current Assets |
||||||||||||
Cash and cash equivalents |
$ | 250,949 | $ | 254,779 | ||||||||
Restricted cash |
1,632 | 3,634 | ||||||||||
Short-term investments |
7,984 | 9,986 | ||||||||||
Trading securities |
768 | 832 | ||||||||||
Accounts receivable, less allowances ($3,637 - 2003; $3,523 - 2002) |
125,526 | 179,668 | ||||||||||
Inventories |
26,327 | 30,181 | ||||||||||
Prepaid expenses and other current assets |
14,610 | 13,045 | ||||||||||
Total current assets |
427,796 | 492,125 | ||||||||||
Property and equipment, net |
38,140 | 38,610 | ||||||||||
Ownership interests in and advances to affiliates |
77,691 | 74,859 | ||||||||||
Available-for-sale securities |
4,474 | 4,548 | ||||||||||
Intangible assets, net |
17,209 | 18,580 | ||||||||||
Goodwill, net |
206,513 | 206,815 | ||||||||||
Deferred taxes |
847 | 1,210 | ||||||||||
Note receivable - related party |
13,751 | 14,482 | ||||||||||
Other |
15,365 | 17,437 | ||||||||||
Total Assets |
$ | 801,786 | $ | 868,666 | ||||||||
Current Liabilities |
||||||||||||
Current maturities of long-term debt |
$ | 12,043 | $ | 11,517 | ||||||||
Accounts payable |
90,598 | 121,793 | ||||||||||
Accrued expenses and deferred revenue |
94,372 | 116,669 | ||||||||||
Total current liabilities |
197,013 | 249,979 | ||||||||||
Long-term debt |
2,221 | 1,998 | ||||||||||
Minority interest |
129,620 | 130,384 | ||||||||||
Other long-term liabilities |
15,550 | 14,032 | ||||||||||
Convertible subordinated notes |
200,000 | 200,000 | ||||||||||
Commitments and contingencies |
||||||||||||
Shareholders Equity |
||||||||||||
Preferred stock, $10.00 par value; 1,000 shares authorized |
| | ||||||||||
Common stock, $0.10 par value; 500,000 shares authorized; 119,450 shares issued
and outstanding in 2003 and 2002 |
11,945 | 11,945 | ||||||||||
Additional paid-in capital |
738,282 | 738,282 | ||||||||||
Accumulated deficit |
(492,406 | ) | (476,867 | ) | ||||||||
Accumulated other comprehensive income |
2,474 | 2,522 | ||||||||||
Treasury stock, at cost (136 shares-2003; 33 shares-2002) |
(396 | ) | (129 | ) | ||||||||
Unamortized deferred compensation |
(2,517 | ) | (3,480 | ) | ||||||||
Total shareholders equity |
257,382 | 272,273 | ||||||||||
Total Liabilities and Shareholders Equity |
$ | 801,786 | $ | 868,666 | ||||||||
See Notes to Consolidated Financial Statements.
3
SAFEGUARD SCIENTIFICS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
| Three Months Ended March 31, | ||||||||||
| 2003 | 2002 | |||||||||
| (in thousands, except per share data) | ||||||||||
| (unaudited) | ||||||||||
Revenue |
||||||||||
Product sales |
$ | 260,311 | $ | 262,767 | ||||||
Service sales |
109,489 | 82,463 | ||||||||
Other |
899 | 5,574 | ||||||||
Total revenue |
370,699 | 350,804 | ||||||||
Operating Expenses |
||||||||||
Cost of sales-product |
235,906 | 233,258 | ||||||||
Cost of sales-service |
72,549 | 54,920 | ||||||||
Selling and service |
34,875 | 29,487 | ||||||||
General and administrative |
30,724 | 34,634 | ||||||||
Depreciation and amortization |
7,878 | 7,401 | ||||||||
Total operating expenses |
381,932 | 359,700 | ||||||||
| (11,233 | ) | (8,896 | ) | |||||||
Other income (loss), net |
4,191 | (5,531 | ) | |||||||
Impairment related party (Note 15) |
(659 | ) | | |||||||
Interest income |
1,032 | 2,020 | ||||||||
Interest and financing expense |
(3,444 | ) | (7,465 | ) | ||||||
Loss before income taxes, minority interest, equity loss and change in accounting principle |
(10,113 | ) | (19,872 | ) | ||||||
Income taxes |
(1,392 | ) | (1,118 | ) | ||||||
Minority interest |
(10 | ) | (841 | ) | ||||||
Equity loss |
(4,024 | ) | (18,907 | ) | ||||||
Net loss before change in accounting principle |
(15,539 | ) | (40,738 | ) | ||||||
Cumulative effect of change in accounting principle (Note 3) |
| (21,390 | ) | |||||||
Net Loss |
$ | (15,539 | ) | $ | (62,128 | ) | ||||
Basic Loss Per Share: |
||||||||||
Prior to cumulative effect of change in accounting principle |
$ | (0.13 | ) | $ | (0.35 | ) | ||||
Cumulative effect of change in accounting principle |
| (0.18 | ) | |||||||
| $ | (0.13 | ) | $ | (0.53 | ) | |||||
Diluted Loss Per Share: |
||||||||||
Prior to cumulative effect of change in accounting principle |
$ | (0.14 | ) | $ | (0.35 | ) | ||||
Cumulative effect of change in accounting principle |
| (0.18 | ) | |||||||
| $ | (0.14 | ) | $ | (0.53 | ) | |||||
Weighted Average Shares Outstanding - Basic and Diluted |
118,163 | 117,523 | ||||||||
See Notes to Consolidated Financial Statements.
4
SAFEGUARD SCIENTIFICS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended March 31, | |||||||||
| 2003 | 2002 | ||||||||
| (in thousands) | |||||||||
| (unaudited) | |||||||||
Net cash used in operating activities |
$ | (4,861 | ) | $ | (28,284 | ) | |||
Investing Activities |
|||||||||
Proceeds from sales of available-for-sale and trading securities |
49 | 13,167 | |||||||
Proceeds from sales of and distributions from affiliates |
5,252 | 9,211 | |||||||
Advances to affiliates |
| (2,241 | ) | ||||||
Repayment of advances to affiliates |
753 | | |||||||
Acquisitions of ownership interests in affiliates and subsidiaries, net of cash acquired |
(5,670 | ) | (5,096 | ) | |||||
Repayments of advances to related party |
72 | 1,372 | |||||||
Increase
in restricted cash and short-term investments |
| (1,609 | ) | ||||||
Decrease in restricted cash and short-term investments |
4,004 | | |||||||
Capital expenditures |
(3,888 | ) | (2,143 | ) | |||||
Other, net |
(341 | ) | (535 | ) | |||||
Net cash provided by investing activities |
231 | 12,126 | |||||||
Financing Activities |
|||||||||
Borrowings on revolving credit facilities |
1,346 | 6,629 | |||||||
Repayments on revolving credit facilities |
| (7,151 | ) | ||||||
Borrowings on long-term debt |
80 | 569 | |||||||
Repayments on long-term debt |
(698 | ) | (786 | ) | |||||
Issuance of subsidiary common stock |
72 | 420 | |||||||
Net cash provided by (used in) financing activities |
800 | (319 | ) | ||||||
Net Decrease in Cash and Cash Equivalents |
(3,830 | ) | (16,477 | ) | |||||
Cash and Cash Equivalents at beginning of period |
254,779 | 298,095 | |||||||
Cash and Cash Equivalents at end of period |
$ | 250,949 | $ | 281,618 | |||||
See Notes to Consolidated Financial Statements.
5
SAFEGUARD SCIENTIFICS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2003
1. GENERAL
The accompanying unaudited interim Consolidated Financial Statements were prepared in accordance with accounting principles generally accepted in the United States of America and the interim financial statements rules and regulations of the SEC. In the opinion of management, these statements include all adjustments (consisting only of normal recurring adjustments) necessary for a fair presentation of the Consolidated Financial Statements. The interim operating results are not necessarily indicative of the results for a full year or for any interim period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations relating to interim financial statements. The Consolidated Financial Statements included in this Form 10-Q should be read in conjunction with Managements Discussion and Analysis of Financial Condition and Results of Operations and the Companys Consolidated Financial Statements and Notes thereto included in the Companys 2002 Annual Report on Form 10-K.
2. BASIS OF PRESENTATION
The Consolidated Financial Statements include the accounts of the Company and all subsidiaries in which it directly or indirectly owns more than 50% of the outstanding voting securities. The Companys wholly-owned subsidiaries include Alliance Consulting Group Associates, Inc. (Alliance Consulting). The Companys Consolidated Statements of Operations and Cash Flows also include the following majority-owned subsidiaries:
| For the three months ended March 31, | ||
| 2003 | 2002 | |
| Agari Mediaware | Agari Mediaware | |
| ChromaVision Medical Systems | Aptas (through March 2002) | |
| CompuCom Systems | CompuCom Systems | |
| Mantas | Pacific Title and Arts Studio | |
| Pacific Title and Arts Studio | Protura Wireless (since January 2002) | |
| Protura Wireless | SOTAS | |
| SOTAS | Tangram Enterprise Solutions | |
| Tangram Enterprise Solutions | ||
The Companys Consolidated Balance Sheets also include the following majority-owned subsidiaries at both March 31, 2003 and December 31, 2002:
| Agari Mediaware |
| ChromaVision Medical Systems |
| CompuCom Systems |
| Mantas |
| Pacific Title and Arts Studio |
| Protura Wireless |
| SOTAS |
| Tangram Enterprise Solutions |
6
SAFEGUARD SCIENTIFICS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
MARCH 31, 2003
3. RECLASSIFICATIONS
Certain prior year amounts have been reclassified to conform to the current year presentation.
The Company adopted SFAS 142, Goodwill and Other Intangible Assets during the three months ended June 30, 2002, effective January 1, 2002. In accordance with the provision of SFAS 142, the Company recorded a cumulative effect of a change in accounting principle in the Consolidated Statements of Operations, resulting in an increase in the Companys net loss by $21.8 million for the three months ended March 31, 2002.
4. GOODWILL AND OTHER INTANGIBLE ASSETS
Under the transition provisions of SFAS 142, the Company was required to test existing goodwill and intangible assets with indefinite useful lives for impairment as of January 1, 2002. The Company completed the required testing during the second quarter of 2002. As a result, the Company reported a $21.8 million goodwill impairment loss in the Business and IT services reporting unit (a component of the Strategic Initiative segment), arising from the initial application of SFAS 142 which required the carrying amount of goodwill be compared to the fair value. The fair value of that reporting unit was determined by estimating the present value of future cash flows and by reviewing the valuations of comparable public companies.
Goodwill balances are consistent with the December 31, 2002 balances. There is an immaterial purchase price adjustment related to the recent acquisition of Alliance Consulting, which is included in the strategic initiative segment (Note 14).
The following is a summary of changes in the carrying amount of goodwill by segment:
| Strategic | ||||||||||||||||
| Initiative | Legacy | Total | ||||||||||||||
| Companies | Companies | CompuCom | Segments | |||||||||||||
| (in thousands) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
Balance at December 31, 2002 |
$ | 91,337 | $ | 10,589 | $ | 104,889 | $ | 206,815 | ||||||||
Acquisitions |
(302 | ) | | | (302 | ) | ||||||||||
Balance at March 31, 2003 |
$ | 91,035 | $ | 10,589 | $ | 104,889 | $ | 206,513 | ||||||||
Intangible assets with definite useful lives are amortized over their respective estimated useful lives to their estimated residual values. The following table provides a summary of the Companys intangible assets with definite useful lives:
| March 31, 2003 | ||||||||||||||||
| Gross | ||||||||||||||||
| Amortization | Carrying | Accumulated | ||||||||||||||
| Period | Value | Amortization | Net | |||||||||||||
| (in thousands) | ||||||||||||||||
| (unaudited) | ||||||||||||||||
Customer-related |
6 - 11 years | $ | 15,467 | $ | 9,700 | $ | 5,767 | |||||||||
Contract-related |
2 - 3 years | 2,840 | 1,601 | 1,239 | ||||||||||||
Technology-related |
2 - 17 years | 14,307 | 4,104 | 10,203 | ||||||||||||
Total |
$ | 32,614 | $ | 15,405 | $ | 17,209 | ||||||||||
7
SAFEGUARD SCIENTIFICS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
MARCH 31, 2003
| December 31, 2002 | ||||||||||||||||
| Gross | ||||||||||||||||
| Amortization | Carrying | Accumulated | ||||||||||||||
| Period | Value | Amortization | Net | |||||||||||||
| (in thousands) | ||||||||||||||||
Customer-related |
6 - 11 years | $ | 15,467 | $ | 9,107 | $ | 6,360 | |||||||||
Contract-related |
2 - 3 years | 2,840 | 1,382 | 1,458 | ||||||||||||
Technology-related |
2 - 17 years | 14,071 | 3,309 | 10,762 | ||||||||||||
Total |
$ | 32,378 | $ | 13,798 | $ | 18,580 | ||||||||||
Amortization expense related to intangible assets was $1.6 million and $1.0 million for the three months ended March 31, 2003 and 2002, respectively. The following table provides estimated future amortization expense related to intangible assets:
| Total | ||||
| (in thousands) | ||||
| (unaudited) | ||||
Remainder of 2003 |
$ | 4,611 | ||
2004 |
5,529 | |||
2005 |
3,614 | |||
2006 |
1,488 | |||
2007 and thereafter |
1,967 | |||
| $ | 17,209 | |||
5. NEW ACCOUNTING PRONOUNCEMENTS
In August 2001, the FASB issued Statement of Financial Accounting Standards No. 143, Accounting for Asset Retirement Obligations. SFAS 143 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred. The Company has adopted SFAS 143 as of January 1, 2003. The adoption did not have any significant impact on its financial statements.
In July 2002, the FASB Issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities, which addresses the financial accounting and reporting of expenses related to restructurings initiated after 2002, and applies to costs associated with an exit activity (including a restructuring) or with a disposal of long-lived assets. Those activities can include eliminating or reducing product lines, terminating employees and contracts, and relocating plant facilities or personnel. Under SFAS No.146, a company will record a liability for a cost associated with an exit or disposal activity when the liability is incurred and can be measured at fair value. The provisions of SFAS No. 146 are effective prospectively for exit or disposal activities initiated after December 31, 2002. The adoption of this statement had no effect on the Companys financial statements.
In November 2002, the FASB issued FASB Interpretation No. 45, Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others, an Interpretation of FASB Statements No. 5, 57, and 107 and rescission of FASB Interpretation No. 34. The Interpretation expands on the disclosure requirements to be made in interim and annual financial statements. The disclosure requirements are effective for financial statements of both interim and annual periods that end after December 15, 2002. The Interpretation also requires that a liability measured at fair value be recognized for guarantees even if the probability of payment on the guarantee is remote. The provision for initial recognition and measurement should be applied on a prospective basis to guarantees issued or modified after December 31, 2002. The Company adopted the provisions of FASB Interpretation No. 45 as of January 1, 2003. The adoption did not have a material impact on the Companys financial statements.
8
SAFEGUARD SCIENTIFICS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS(Continued)
MARCH 31, 2003
In November 2002, the Emerging Issues Task Force (EITF) reached a consensus on Issue No. 00-21, Accounting for Revenue Arrangements with Multiple Deliverables. This issue addresses the appropriate accounting by vendors for arrangements that will result in the delivery of multiple products, services and/or rights to assets that may occur over a period of time. The Issue is effective for revenue arrangements entered into in fiscal periods beginning after June 15, 2003. The Company is currently evaluating the impact of the adoption of this consensus on the Companys consolidated financial statements.
In January 2003, the FASB issued Interpretation No. 46, which addresses the consolidation by business enterprises of variable interest entities as defined in the Interpretation. The Interpretation applies immediately to variable